“When we own portions of outstanding businesses with outstanding managements, our favorite holding period is forever.”
— Warren Buffett
A long-term investment in Humana Inc. (NYSE: HUM) illustrates how compounding, price appreciation, and dividend reinvestment can shape total shareholder returns over an extended holding period. Based on the return profile shown below, a $10,000 investment in HUM made in September 2006 would have grown to $73,816.00 by September 1, 2026, assuming dividends were reinvested.
That equates to a total return of 637.92% and an average annual return of 10.51%. Put differently, Humana stock produced a result that materially exceeded the original capital committed, even though the company’s dividend yield remained modest for much of the period. The case is a useful reminder that long-run equity returns often come from a combination of business growth and disciplined reinvestment rather than headline yield alone.
HUM 20-Year Return Details
| Start date: | 09/05/2006 |
|
|||
| End date: | 09/01/2026 | ||||
| Start price/share: | $61.43 | ||||
| End price/share: | $394.88 | ||||
| Starting shares: | 162.79 | ||||
| Ending shares: | 186.87 | ||||
| Dividends reinvested/share: | $32.91 | ||||
| Total return: | 637.92% | ||||
| Average annual return: | 10.51% | ||||
| Starting investment: | $10,000.00 | ||||
| Ending investment: | $73,816.00 | ||||
As the table shows, the bulk of the value creation came from sustained share-price appreciation, with dividend reinvestment adding incremental share accumulation along the way. Starting shares of 162.79 increased to 186.87 through reinvested distributions, demonstrating how even a relatively low-yielding stock can benefit from long-term reinvestment.
These figures were computed with the Dividend Channel DRIP Returns Calculator, using the assumption that dividends were reinvested into additional shares at the closing price on the ex-dividend date.
What Drove the Long-Term Return in Humana Stock?
Humana has historically been viewed as a managed-care and health insurance company with meaningful exposure to government-sponsored programs, particularly Medicare-related coverage. Over long periods, companies in this segment can benefit from scale, recurring premium revenue, and operating leverage, although returns also depend heavily on medical cost trends, reimbursement dynamics, regulation, and execution.
For HUM, the 20-year return profile shown here suggests that investors were rewarded less by current income and more by the market’s willingness over time to assign higher value to the company’s earnings power and cash-generation potential. That distinction matters. A stock does not need to be a high-yielder to produce strong total returns if underlying business performance supports durable appreciation.
Humana Dividend Yield and Yield on Cost
Dividends still played a meaningful, if secondary, role in the investment outcome. Over the 20-year period referenced above, Humana paid $32.91 per share in cumulative dividends. Reinvesting those payments increased the share count and lifted the ending value of the original investment.
Using the most recent annualized dividend rate of $3.54 per share, HUM has a current yield of approximately 0.90% based on the ending share price of $394.88. On a yield-on-cost basis, that same $3.54 annualized dividend represents about 1.47% of the original $61.43 purchase price.
Yield on cost is useful for illustrating how an income stream evolves relative to the original entry price, but it should not be confused with current yield, which reflects the dividend relative to the stock’s present market price. For valuation and portfolio allocation decisions, current yield is generally the more relevant measure; for tracking the income progression of a legacy holding, yield on cost can be informative.
Key Takeaways From a $10,000 Investment in HUM
The long-term Humana investment result can be summarized in a few points:
- A $10,000 investment in HUM on 09/05/2006 grew to $73,816.00 by 09/01/2026.
- The investment generated a total return of 637.92%.
- The average annual return was 10.51%.
- Dividend reinvestment increased the share count from 162.79 to 186.87.
- The result highlights the importance of total return, not just dividend yield, when evaluating long-term holdings.
Why Total Return Matters More Than Yield Alone
Humana’s return history is a straightforward example of why total return analysis is essential. Screening exclusively for high-yield stocks can overlook companies that distribute less cash today but create substantial shareholder value through earnings growth, margin expansion, and multiple years of compounded price appreciation. In contrast, a higher-yielding stock may generate more current income while delivering weaker overall capital growth.
That does not make yield irrelevant. Rather, it places dividend yield in context. For a long-duration holding, the more important question is how dividends, reinvestment, and underlying business performance interact over time to shape the full return profile.
“If you’re prepared to invest in a company, then you ought to be able to explain why in simple language that a fifth grader could understand, and quickly enough so
